Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Vozoris NT, Yao Z, Li P, Austin PC, Stephenson AL, Gill SS, O'Donnell DE, Gershon AS, Rochon PA.

Drugs Aging. 2019 Sep 24. doi: 10.1007/s40266-019-00707-3. [Epub ahead of print]

PMID:
31552597
2.

Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.

Kendzerska T, Aaron SD, To T, Licskai C, Stanbrook M, Vozoris NT, Hogan ME, Tan WC, Bourbeau J, Gershon AS.

Ann Am Thorac Soc. 2019 Oct;16(10):1252-1262. doi: 10.1513/AnnalsATS.201902-126OC.

PMID:
31298938
3.

Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study.

Gershon AS, Thiruchelvam D, Aaron S, Stanbrook M, Vozoris N, Tan WC, Cho E, To T.

PLoS One. 2019 May 21;14(5):e0216741. doi: 10.1371/journal.pone.0216741. eCollection 2019.

4.

Benzodiazepine and opioid co-usage in the US population, 1999-2014: an exploratory analysis.

Vozoris NT.

Sleep. 2019 Apr 1;42(4). pii: zsy264. doi: 10.1093/sleep/zsy264.

PMID:
30657987
5.

Statistical compared to clinical significance and the risk of misattribution.

Vozoris NT, Austin PC, Rochon PA.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801868. doi: 10.1183/13993003.01868-2018. Print 2018 Nov. No abstract available.

PMID:
30498054
6.

Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.

Faughnan ME, Gossage JR, Chakinala MM, Oh SP, Kasthuri R, Hughes CCW, McWilliams JP, Parambil JG, Vozoris N, Donaldson J, Paul G, Berry P, Sprecher DL.

Angiogenesis. 2019 Feb;22(1):145-155. doi: 10.1007/s10456-018-9646-1. Epub 2018 Sep 6.

7.

Serotonergic antidepressant use and morbidity and mortality among older adults with COPD.

Vozoris NT, Wang X, Austin PC, Stephenson AL, O'Donnell DE, Gershon AS, Gill SS, Rochon PA.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800475. doi: 10.1183/13993003.00475-2018. Print 2018 Jul.

PMID:
29946006
8.

Opioids, Chronic Obstructive Pulmonary Disease, and Hyperbole.

Vozoris NT.

J Palliat Med. 2018 Jun;21(6):745. doi: 10.1089/jpm.2018.0090. No abstract available.

PMID:
29889015
9.

Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic.

Chien K, Seemangal J, Batt J, Vozoris NT.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):681-685. doi: 10.5588/ijtld.17.0685.

PMID:
29862954
10.

Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.

Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS.

Br J Clin Pharmacol. 2018 Mar;84(3):579-589. doi: 10.1111/bcp.13465. Epub 2017 Dec 6.

11.

Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Vozoris NT, Wang X, Austin PC, Lee DS, Stephenson AL, O'Donnell DE, Gill SS, Rochon PA.

Eur J Clin Pharmacol. 2017 Oct;73(10):1287-1295. doi: 10.1007/s00228-017-2278-3. Epub 2017 Jun 29.

PMID:
28664359
12.

Prescription opioid use in advanced COPD: benefits, perils and controversies.

Vozoris NT.

Eur Respir J. 2017 Jun 22;49(6). pii: 1700479. doi: 10.1183/13993003.00479-2017. Print 2017 Jun. No abstract available.

13.

The harms of benzodiazepines for patients with dementia.

Rochon PA, Vozoris N, Gill SS.

CMAJ. 2017 Apr 10;189(14):E517-E518. doi: 10.1503/cmaj.170193. No abstract available.

14.

Incident opioid use is associated with risk of respiratory harm in non-palliative COPD.

Vozoris NT, O'Donnell DE, Bell C, Gill SS, Rochon PA.

Eur Respir J. 2017 Mar 8;49(3). pii: 1602529. doi: 10.1183/13993003.02529-2016. Print 2017 Mar. No abstract available.

15.

The need for greater opioid pharmacovigilance in COPD.

Vozoris NT.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 6;12:189-192. doi: 10.2147/COPD.S128441. eCollection 2017. No abstract available.

16.

Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients.

Vozoris NT, O'Donnell DE, Gill SS.

Eur Respir J. 2016 Dec;48(6):1818. doi: 10.1183/13993003.01690-2016. No abstract available.

17.

Opioids in COPD: a cause of death or a marker of illness severity?

Vozoris NT, O'Donnell DE, Bell CM, Gill SS, Rochon PA.

Eur Respir J. 2016 Nov;48(5):1521-1522. doi: 10.1183/13993003.01573-2016. No abstract available.

18.

Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD.

Gershon AS, Newman AM, Fischer HD, Austin PC, Daneman N, Bell CM, Stephenson AL, Gill SS, Vozoris NT, Rochon PA.

COPD. 2017 Feb;14(1):105-112. doi: 10.1080/15412555.2016.1202912. Epub 2016 Oct 12.

PMID:
27732117
19.

Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012.

Vozoris NT, Batt J.

Can Respir J. 2016;2016:1850879. doi: 10.1155/2016/1850879. Epub 2016 May 30.

20.

Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Wang X, Fischer HD, Bell CM, O'Donnell DE, Austin PC, Stephenson AL, Gill SS, Rochon PA.

Eur Respir J. 2016 Sep;48(3):683-93. doi: 10.1183/13993003.01967-2015. Epub 2016 Jul 13.

21.

The need to address increasing opioid use in elderly COPD patients.

Vozoris NT, O'Donnell DE.

Expert Rev Respir Med. 2016;10(3):245-8. doi: 10.1586/17476348.2016.1143776. Epub 2016 Feb 6. No abstract available.

PMID:
26783198
22.

Insomnia Symptoms Are Not Associated with Dyslipidemia: A Population-Based Study.

Vozoris NT.

Sleep. 2016 Mar 1;39(3):551-8. doi: 10.5665/sleep.5524.

23.

Opioids in COPD: the 'whole picture' includes results from real-world, population-based observational studies.

Vozoris NT, Gill SS, O'Donnell DE.

Br J Clin Pharmacol. 2016 Apr;81(4):797-8. doi: 10.1111/bcp.12838. Epub 2016 Jan 4. No abstract available.

24.

Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Vozoris NT, Wang X, Fischer HD, Gershon AS, Bell CM, Gill SS, O'Donnell DE, Austin PC, Stephenson AL, Rochon PA.

Br J Clin Pharmacol. 2016 Jan;81(1):161-70. doi: 10.1111/bcp.12762. Epub 2015 Oct 2.

25.

Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Stephenson AL.

Eur Respir J. 2015 Feb;45(2):566-7. doi: 10.1183/09031936.00172714. No abstract available.

26.

Smoking, activity level and exercise test outcomes in a young population sample without cardiopulmonary disease.

Vozoris NT, O'donnell DE.

J Sports Med Phys Fitness. 2015 Jul-Aug;55(7-8):787-96. Epub 2015 Jan 22.

PMID:
25611081
27.

Response to Ekström et al regarding low-dose opioids in advanced chronic obstructive pulmonary disease.

Vozoris NT.

Evid Based Med. 2015 Feb;20(1):40. doi: 10.1136/ebmed-2014-110141. Epub 2015 Jan 6. No abstract available.

PMID:
25564657
28.

Do benzodiazepines contribute to respiratory problems?

Vozoris NT.

Expert Rev Respir Med. 2014 Dec;8(6):661-3. doi: 10.1586/17476348.2014.957186. Epub 2014 Sep 5.

PMID:
25193249
29.

Insomnia symptom frequency and hypertension risk: a population-based study.

Vozoris NT.

J Clin Psychiatry. 2014 Jun;75(6):616-23. doi: 10.4088/JCP.13m08818.

PMID:
25004185
30.

Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients.

Vozoris NT, Seemangal J, Batt J.

Eur Respir J. 2014 Nov;44(5):1373-5. doi: 10.1183/09031936.00076714. Epub 2014 Jun 25. No abstract available.

31.

Benzodiazepines and opioids need to be prescribed with caution in advanced COPD.

Vozoris NT.

Evid Based Med. 2014 Oct;19(5):170. doi: 10.1136/eb-2014-101789. Epub 2014 May 1. No abstract available.

PMID:
24785470
32.

Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, Austin PC, Anderson GM, Bell CM, Gill SS, Rochon PA.

Eur Respir J. 2014 Aug;44(2):332-40. doi: 10.1183/09031936.00008014. Epub 2014 Apr 17.

33.

Management of chronic obstructive pulmonary disease exacerbations: how well are we doing?

Vozoris NT.

Can Respir J. 2013 May-Jun;20(3):157-8. No abstract available.

34.

The relationship between insomnia symptoms and hypertension using United States population-level data.

Vozoris NT.

J Hypertens. 2013 Apr;31(4):663-71. doi: 10.1097/HJH.0b013e32835ed5d0.

PMID:
23391985
35.

Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, Stephenson AL, Gill SS, Rochon PA.

Drugs Aging. 2013 Mar;30(3):183-92. doi: 10.1007/s40266-013-0056-1.

PMID:
23371396
37.

Mentholated cigarettes and cardiovascular and pulmonary diseases: a population-based study.

Vozoris NT.

Arch Intern Med. 2012 Apr 9;172(7):590-1. doi: 10.1001/archinternmed.2012.320. No abstract available.

PMID:
22493467
38.

Sleep apnea-plus: prevalence, risk factors, and association with cardiovascular diseases using United States population-level data.

Vozoris NT.

Sleep Med. 2012 Jun;13(6):637-44. doi: 10.1016/j.sleep.2012.01.004. Epub 2012 Apr 3. Erratum in: Sleep Med. 2012 Dec;13(10):1327.

PMID:
22475994
39.
40.

Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma.

Vozoris NT, Stanbrook MB.

Respir Med. 2011 Mar;105(3):477-84. doi: 10.1016/j.rmed.2010.08.011. Epub 2010 Sep 17.

41.

Influenza vaccination among Canadians with chronic respiratory disease.

Vozoris NT, Lougheed MD.

Respir Med. 2009 Jan;103(1):50-8. doi: 10.1016/j.rmed.2008.08.004. Epub 2008 Sep 24.

43.

The health of Canadians on welfare.

Vozoris NT, Tarasuk VS.

Can J Public Health. 2004 Mar-Apr;95(2):115-20.

PMID:
15074901
44.

Household food insufficiency is associated with poorer health.

Vozoris NT, Tarasuk VS.

J Nutr. 2003 Jan;133(1):120-6.

PMID:
12514278
45.

The affordability of a nutritious diet for households on welfare in Toronto.

Vozoris N, Davis B, Tarasuk V.

Can J Public Health. 2002 Jan-Feb;93(1):36-40.

PMID:
11925698

Supplemental Content

Loading ...
Support Center